Middle EAST Spine Biologic Market Strategy Review: Competitive Landscape and Growth Drivers
The Middle EAST Spine Biologic Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by a combination of rising incidences of spinal disorders, advancements in surgical techniques, and an increasing preference for minimally invasive procedures. The demand for biologics in spinal surgeries...
0 التعليقات 0 المشاركات 888 المشاهدات
Sngine France : Partagez Vos Moments, Faites de Nouveaux Amis https://sngine.fr